Ledger.Open graph →
SEC Form D · filed March 13, 2023

QurAlis Corp

Offering
$88.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (41)

Kasper C. Roet · Cambridge, MAExec · Director · PromoterLaia C. Crespo-Martin · Cambridge, MADirectorMichael C. Hutton · Cambridge, MADirectorJohannes C. Fruehauf · Cambridge, MADirectorDaniel C. Elbaum · Cambridge, MAExecHagen C. Cramer · Cambridge, MAExecCillian C. King · Cambridge, MADirectorAnne C. Whitaker · Cambridge, MADirectorLuc C. Dochez · Cambridge, MADirectorAmy C. Schulman · Cambridge, MADirectorVikas C. Sharma · Cambridge, MAExecChris C. Thomajan · Cambridge, MAExecAngela C. Genge · Cambridge, MAExecJulio E. Vega · NEW YORK, NYExecSebastian Milla · Lincoln, NEDirectorJonathan E. Slager · Salt Lake City, UTExecMatt Tucker · Salt Lake City, UTDirectorMike Sodo · Salt Lake City, UTDirectorJasmine Kingsley · Lincoln, NEExecTim Warman · VANCOUVER, British Columbia, CanadaExec · Director · PromoterRobert E. Morse · Salt Lake City, UTExecChristopher Kingsley · Lincoln, NEDirectorAdam E. O'Farrell · Salt Lake City, UTExecScott Hicks · VANCOUVER, British Columbia, CanadaExecRobert M. Kennedy · Durham, NCDirectorJames C. Collins, Jr · Durham, NCDirectorGino Zandonai · VANCOUVER, British Columbia, CanadaDirectorRyan Westwood · Salt Lake City, UTExecKent Madsen · Salt Lake City, UTExecConnor Estrick · Tampa, FLExecSteven Estrick · Tampa, FLDirectorElyse M. Mclaughlin · Newark, NJDirectorKelly A. Coyne · Newark, NJDirectorMelissa R. Gonzalez · Newark, NJExecAndrew R. French · Newark, NJDirectorPatrick E. Mcguinness · Newark, NJExec · Director · PromoterThomas M. Turpin · Newark, NJDirectorDevan E. Goolsby · Newark, NJExecAndrew Rosen · Miami, FLDirectorDmitriy Azarenko · Miami, FLDirectorJulio E. Vega · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗